Physician profile
Bianca D Alfonso
NPI 1013159763
$14,276.71
in general payments reported to CMS, 2019-2025
67 companies · $2,424 in 2025
The $2,424 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,742 · 2020: $1,382 · 2021: $799 · 2022: $1,562 · 2023: $2,739 · 2024: $2,628 · 2025: $2,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,791.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,783.17 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,310.50 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Tandem Diabetes Care, INC. | $889.20 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $735.59 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $720.10 | 2019-2025 | Synthroid |
| Amgen INC. | $691.12 | 2019-2025 | Evenity, Tepezza, Prolia |
| Insulet Corporation | $651.12 | 2019-2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.89 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Mannkind Corporation | $531.73 | 2019-2025 | Afrezza |
| Sanofi-Aventis U.S. LLC | $514.38 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $509.88 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Astrazeneca Pharmaceuticals LP | $477.06 | 2019-2023 | Lokelma, Farxiga |
| Radius Health, INC. | $466.34 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $383.71 | 2019-2025 | Unithroid |
| Recordati_rare_diseases_inc. | $348.25 | 2022-2025 | Isturisa, Signifor Lar |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $249.34 | 2019-2025 | Tirosint, Licart, Tirosint |
| Pfizer INC. | $230.57 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $213.60 | 2023-2025 | |
| Dexcom, INC. | $209.68 | 2023-2025 | Dexcom G6 Transmitter |
| Alvogen INC | $192.77 | 2022-2025 | Teriparatide |
| Corcept Therapeutics | $177.34 | 2020-2025 | Korlym |
| Medtronic, INC. | $166.25 | 2021-2024 | Minimed 780g, Mycarelink |
| Beta Bionics, INC. | $152.33 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Antares Pharma, INC. | $144.04 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Cequr Corporation | $128.54 | 2022-2024 | Cequr Simplicity |
| Becton, Dickinson and Company | $119.52 | 2019-2022 | |
| Amarin Pharma, INC. | $95.12 | 2019-2022 | |
| Vivus LLC | $91.81 | 2019-2024 | Qsymia, Pancreaze |
| Horizon Therapeutics Plc | $91.31 | 2019-2023 | Tepezza |
| Verity Pharmaceuticals INC. | $88.02 | 2025 | Tlando |
| Alexion Pharmaceuticals, INC. | $87.80 | 2021-2025 | Strensiq |
| Embecta Corp. | $83.06 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Merck Sharp & Dohme LLC | $80.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $75.33 | 2019 | |
| Currax Pharmaceuticals LLC | $70.72 | 2019-2022 | |
| Ascendis Pharma Endocrinology INC | $63.69 | 2025 | Yorvipath |
| Kyowa Kirin, INC. | $63.20 | 2023-2025 | Crysvita |
| Shire North American Group INC | $59.40 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $57.76 | 2023-2025 | Baqsimi |
| Neurocrine Biosciences, INC. | $48.86 | 2025 | |
| Senseonics, Incorporated | $46.00 | 2019-2020 | |
| Sequel Med Tech, LLC | $44.99 | 2025 | Twiist |
| Halozyme INC | $44.51 | 2023 | |
| Zealand Pharma US, INC. | $41.42 | 2021 | |
| Theratechnologies INC. | $40.60 | 2025 | Trogarzo, Egrifta |
| Valeritas, INC. | $37.38 | 2019 | |
| Ascend Therapeutics US, LLC | $33.41 | 2022 | |
| Lifescan, INC. | $26.87 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $26.73 | 2023 | |
| Eusa Pharma (US) LLC | $24.30 | 2022 | |
| Medtronic Minimed, INC. | $23.61 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $22.04 | 2025 | Imcivree |
| Madrigal Pharmaceuticals | $21.81 | 2025 | Rezdiffra |
| Chiesi USA, INC. | $21.76 | 2024 | Mycapssa |
| Ipsen Biopharmaceuticals, INC | $21.45 | 2020 | |
| Aimmune Therapeutics, INC. | $19.99 | 2025 | Zenpep |
| Evoke Pharma, INC. | $19.26 | 2025 | |
| Amryt Pharma Holdings LTD | $19.26 | 2022 | |
| Acella Pharmaceuticals, LLC | $19.18 | 2025 | NP Thyroid 60 |
| Ascensia Diabetes Care US INC. | $18.93 | 2025 | |
| Alfasigma USA, INC. | $18.29 | 2022 | |
| Astellas Pharma US INC | $17.78 | 2024 | Veozah |
| Roche Diabetes Care, INC. | $17.13 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $16.31 | 2019 | |
| Intuity Medical INC | $16.12 | 2022 | |
| Gilead Sciences, INC. | $16.07 | 2020 | |
| Companion Medical, INC. | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Alfonso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.